Abivax CEO Highlights Pipeline Assets, Including Lead HIV Drug
Executive Summary
Abivax CEO Dr. Hartmut Ehrlich talks to Scrip senior editor Lucie Ellis about the progress and next development steps for its lead clinical-stage molecule against HIV virus.